The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunochemistry and immunohistochemistry laboratory testing services. The single-award IDC, valued at $2.3 million, was awarded on November 13, 2020 and has an ultimate completion date of November 12, 2025.
Under this IDC, the VA has placed multiple firm fixed price delivery orders with Roche Diagnostics to provide immunochemistry and immunohistochemistry laboratory testing services at VA facilities in Pittsburgh, Pennsylvania. The total value of these delivery orders is approximately $1.4 million, spanning periods of performance from January 2022 through January 2025. No set-aside designations were used for these awards. As a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, Roche Diagnostics leverages its existing General Services Administration (GSA) Schedule contracts to streamline the VA's acquisition of these critical medical laboratory services in support of healthcare programs for veterans.
Generated 9/7/24, 10:21 AM